Effectiveness and Safety of Direct Oral Anticoagulants Versus Warfarin in Patients With Valvular Atrial Fibrillation
Ann Intern Med
.
2021 Oct;174(10):1490.
doi: 10.7326/L21-0565.
Authors
Ghadeer K Dawwas
1
,
Geoffrey D Barnes
2
,
Adam Cuker
3
,
James D Lewis
1
Affiliations
1
Perelman School of Medicine and Leonard Davis Institute of Health Economics, University of Pennsylvania, Philadelphia, Pennsylvania.
2
University of Michigan, Ann Arbor, Michigan.
3
Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
PMID:
34662171
DOI:
10.7326/L21-0565
No abstract available
Publication types
Letter
Comment
MeSH terms
Anticoagulants / adverse effects
Atrial Fibrillation* / complications
Atrial Fibrillation* / drug therapy
Dabigatran
Humans
Warfarin* / adverse effects
Substances
Anticoagulants
Warfarin
Dabigatran